ELAN Q1 2025 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B-1.0% YoY

Gross Profit

$556M46.6% margin

Operating Income

$121M10.1% margin

Net Income

$67M5.6% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+17.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$69M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$12.9B

Total Liabilities

$6.6B

Stockholders' Equity

$6.4B

Cash & Equivalents

$487M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	-1.0%
Gross Profit	$556M	$557M	-0.2%
Operating Income	$121M	$133M	-9.0%
Net Income	$67M	$32M	+109.4%

Revenue Segments

Pet Health

$635M37%

Farm Animal

$546M31%

Cattle

$272M16%

Poultry

$189M11%

Swine

$85M5%

Contract Manufacturing

$12M1%

Geographic Segments

Non-US

$639M54%

UNITED STATES

$554M46%